Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Pharmacotherapy|January 1, 1990
Patterns of antibiotic use and expenditures during 7 years at a university hospitalC V Fletcher, D Metzler, P Borchardt-Phelps, et al.
Clinical Pharmacology and Therapeutics|August 1, 1988
Pharmacokinetics and safety of high-dose oral acyclovir for suppression of cytomegalovirus disease after renal transplantationC V Fletcher, B J Chinnock, B Chace, et al.
JAMA|March 23, 1990
Treatment of resistant herpes simplex virus with continuous-infusion acyclovirJ P Engel, J A Englund, C V Fletcher, et al.
HIV Clinical Trials|October 9, 2001
Combination therapy with indinavir, ritonavir, and delavirdine and nucleoside reverse transcriptase inhibitors in patients with HIV/AIDS who have failed multiple antiretroviral combinationsM Grodesky, E P Acosta, N Fujita, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Helicase-primase as a target of new therapies for herpes simplex virus infectionsS H James, K B Larson, E P Acosta, et al.
Pharmacotherapy|January 11, 1992
Comparative pharmacokinetics of zidovudine in healthy volunteers and in patients with AIDS with and without hepatic diseaseC V Fletcher, F S Rhame, C C Beatty, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Strategies for control of zidovudine concentrations in serumS E Noormohamed, W K Henry, F S Rhame, et al.
The Annals of Pharmacotherapy|October 1, 1995
Recent advances: antiinfectivesL L Briceland, J D Cleary, C V Fletcher, et al.
Pharmacotherapy|November 1, 1995
The effect of cimetidine and ranitidine administration with zidovudineC V Fletcher, W K Henry, S E Noormohamed, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1989
Continuous infusion of high-dose acyclovir for serious herpesvirus infectionsC V Fletcher, J A Englund, B Bean, et al.
Pageof 8